Based on the clinically proven MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in larger vessels. This innovative system utilizes a unique stent pattern to provide ultra coverage for large coronary arteries. The flexible delivery system provides smooth tracking and enhanced access to large native coronary lesions. It incorporates GRIP Technology for excellent stent retention and provides smooth surface transitions, protecting stent edges and enhancing passage through tight lesions. The low stent-to-shoulder minimizes the amount of balloon outside the stent.
Technology | June 29, 2006
Ultra Coverage for Large Coronary Arteries
News | Stents | October 04, 2018
October 4, 2018 – Investigators unveiled clinical data from the independent BIONYX and SORT OUT IX all-comers trials
Technology | Stents | September 27, 2018
September 27, 2018 — Biotronik recently announced U.S.
Videos | Stents | September 11, 2018
This is an animation showing how the dedicated bifurcation stent developed by Advanced Bifurcation Systems (ABS) is d
News | Stents | January 25, 2018
Elixir Unveils Transformational DynamX Stent Featuring Adaptive Segments that Uncage the Stented Artery
January 25, 2018 – Elixir Medical Corporation, a leader in the development of breakthrough adaptive remodeling techno
News | Stents | November 24, 2017
November 24, 2017 – During a late-breaking session at the European Society of Cardiology (ESC) 2017 meeting, presente
News | Stents | November 10, 2017
Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology portfolio, which now...
Feature | Stents | November 08, 2017
November 8, 2017 – New results from the HARMONEE Japan/U.S.
News | Stents | October 27, 2017
CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of CeloNova's...
Technology | Stents | March 02, 2017
March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc.
News | Stents | January 13, 2017
January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC